Edmond de Rothschild Holding’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Edmond de Rothschild Holding’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-6,450	Closed	-$279K	–	912
2015 Q3	$279K	Buy	+6,450	New	+$272K	0.01%	414

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Edmond de Rothschild Holding's WX Position: Q4 2015 in Review

Edmond de Rothschild Holding sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 6,450 shares — an estimated $279K sold.

Edmond de Rothschild Holding first reported a position in WX in Q3 2015 and held it in 1 quarter. The position peaked at $279K in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Edmond de Rothschild Holding reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Edmond de Rothschild Holding sold 6,450 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $279K.
Edmond de Rothschild Holding first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q3 2015 and held it in 1 quarter.
Edmond de Rothschild Holding's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $279K in Q3 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Edmond de Rothschild Holding's 13F filing for Q4 2015, filed 16 Feb 2016.